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A B S T R A C T
Arsenic is a widely distributed environmental toxin whose presence in drinking water poses a threat to> 140
million people worldwide. The respiratory enzyme arsenite oxidase from various bacteria catalyses the oxidation
of arsenite to arsenate and is being developed as a biosensor for arsenite. The arsenite oxidase from Rhizobium sp.
str. NT-26 (a member of the Alphaproteobacteria) is a heterotetramer consisting of a large catalytic subunit
(AioA), which contains a molybdenum centre and a 3Fe-4S cluster, and a small subunit (AioB) containing a
Rieske 2Fe-2S cluster. Stopped-ﬂow spectroscopy and isothermal titration calorimetry (ITC) have been used to
better understand electron transfer through the redox-active centres of the enzyme, which is essential for bio-
sensor development. Results show that oxidation of arsenite at the active site is extremely fast with a rate
of> 4000 s−1 and reduction of the electron acceptor is rate-limiting. An AioB-F108A mutation results in in-
creased activity with the artiﬁcial electron acceptor DCPIP and decreased activity with cytochrome c, which in
the latter as demonstrated by ITC is not due to an eﬀect on the protein-protein interaction but instead to an eﬀect
on electron transfer. These results provide further support that the AioB F108 is important in electron transfer
between the Rieske subunit and cytochrome c and its absence in the arsenite oxidases from the
Betaproteobacteria may explain the inability of these enzymes to use this electron acceptor.
1. Introduction
Arsenic, in the inorganic forms arsenite (+III) and arsenate (+V),
is toxic to most organisms [1]. The reduction potential of the arsenite/
arsenate couple (+60 mV) [1] is such that certain phylogenetically
diverse bacteria can either use arsenite as an electron donor or arsenate
as a terminal electron acceptor for growth [2]. Aerobic arsenite oxi-
dation is catalysed by arsenite oxidase, Aio, which couples the oxida-
tion of arsenite to the reduction of oxygen to water generating ATP and
in some cases NADH for carbon dioxide ﬁxation [3]. The physiological
electron acceptor for Aio has been shown to be c-type cytochromes or
azurin [4–7].
Aio is a member of the dimethyl sulfoxide reductase (DMSOR) su-
perfamily of molybdoenzymes, which all contain two equivalents of an
organic pyranopterin cofactor coordinated to the molybdenum, usually
present as the dinucleotide of guanine and termed MGD (for mo-
lybdopterin guanine dinucleotide). Aio is unique among members of the
DMSOR superfamily, however, in that the molybdenum is not
coordinated to the protein by an amino acid side chain [8]. The mo-
lybdenum centre of Aio also exhibits highly cooperative two electron
transfer, with the intermediate Mo(V) oxidation state not typically
observed upon reduction of Mo(VI) to Mo(IV) [9] until recently in a
mutant with altered hydrogen bonding to the MGD [10]. Aio also
contains a high potential 3Fe-4S cluster in the large catalytic subunit,
AioA, rather than the more common 4Fe-4S cluster, and a Rieske centre
in the small subunit, AioB, homologous to the Rieske protein in the bc1
and b6f complexes [11,12]. Aio is the only molybdoenzyme to contain a
Rieske 2Fe-2S cluster (in which one of the Fe atoms is complexed by
two histidine residues instead of two cysteines) [13]. An overview of
the redox-active centres in Aio catalysis is shown in Fig. 1. It has been
suggested that the electrons from arsenite oxidation pass to the mo-
lybdenum centre, to the 3Fe-4S cluster, the Rieske cluster and ﬁnally to
an electron acceptor [8,13].
Heterologous expression of the NT-26 Aio in Escherichia coli has
facilitated a more detailed study of the mechanisms of electron transfer
[7,8,10,14] and its development as a biosensor for arsenite [15]. In this
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study, we use a combination of steady-state and stopped-ﬂow kinetics
as well as isothermal titration calorimetry (ITC) to determine the rate-
limiting step of catalysis. Crystallization and structure determination of
the AioB F108A mutant provides evidence of protein integrity and de-
tails of the atomic model of the enzyme. Understanding electron
transfer through the enzyme is critical to further biosensor develop-
ment.
2. Experimental procedures
2.1. Heterologous Aio expression, puriﬁcation and site-directed mutagenesis
The NT-26 aioBA-pPROEX-HTb + construct and E. coli strain DH5α
were used for the aerobic expression of Aio where the ﬁnal culture
volume was 2 L in a 5 L ﬂask, induction with isopropyl β-D-1-thioga-
lactopyranoside was at 21 °C for 24 h and the enzyme puriﬁed as de-
scribed previously [8]. Site-directed mutagenesis to obtain the AioB-
F108A mutant was done as described previously [8] with the following
primers, AioBF108A forward 5′ GTCCTCACAAGGGTGCTCCTCTGAGC-
TACTCCGC 3′ and AioBF108A reverse 5′ GCGGAGTAGCTCAGAGGA-
GCACCCTTGTGAGGAC 3′.
2.2. Enzyme assays
Aio assays measuring steady-state kinetic parameters for arsenite
were performed as described previously using di-
chlorophenolindophenol (DCPIP) [6] (the ε for DCPIP at pH 5.5 used
was 8.2 mM−1 cm−1 [16] instead of 23 mM−1 cm−1 [6]) and horse
heart cytochrome c (Sigma-Aldrich) [14] as electron acceptors. The
steady-state kinetic parameters of cytochrome c were determined using
an excess of arsenite (2.5 mM) and followed the reduction of cyto-
chrome c at 416 nm (Δɛ = 57.5 mM−1 cm−1; based on UV–visible
spectra in 50 mM Tris-HCl (pH 8) using ɛ550 = 8.4 and
29.5 mM−1 cm−1 for oxidised and reduced cytochrome c to determine
the concentration [17]). Kinetics experiments were performed on three
separate occasions with three separate enzyme preparations. NaCl was
not added to any buﬀers as 100 mM reduced the activity of Aio with
cytochrome c to 35% (data not shown). Using salt is also not physio-
logically relevant as the Aio is a periplasmic enzyme which means that
the pH and salt concentration would be in equilibrium with the en-
vironment and NT-26 was isolated from a low-salt environment [18].
2.3. Stopped-ﬂow UV–visible spectroscopy
All experiments were conducted in 50 mM Tris-HCl (pH 8) at 5 °C
using a SX-20 stopped-ﬂow spectrophotometer (Applied Photophysics,
Inc.) equipped with photodiode array and photomultiplier tube detec-
tion and running ProData SX 2.2.5.6 acquisition software. A volume of
1.2 mL of 30 μM Aio was placed in a glass tonometer and made anae-
robic by stirring in an O2 scrubbed Argon rich environment for 1 h. Aio
was reacted with 500 μM arsenite in a stopped-ﬂow apparatus to follow
the reductive half-reaction. Reduction of the molybdenum centre and
[Fe-S] reduction was followed at 680 nm and 450 nm, respectively. To
observe the interaction with cytochrome c, 30 μM Aio was mixed with
60 μM cytochrome c and 30 μM arsenite to catalyse a single turnover.
The rate of cytochrome c reduction was followed at 551 nm. Four to six
replicates were performed with one enzyme preparation. Rate constants
thus determined are presented at 25 °C based on the Arrhenius equation
[19].
2.4. Isothermal titration calorimetry
ITC was carried out using a MicroCal200 ITC and analysed with the
accompanying software (GE Healthcare). A volume of 350 μL of 75 μM
reduced Aio was loaded into the cell in 50 mM Tris-HCl (pH 8) and
40 μL of 750 μM reduced cytochrome c in 50 mM Tris-HCl (pH 8) was
loaded into the injection syringe. The cytochrome c was injected into
the enzyme solution in 1.5 or 2 μL volumes with 1000 rpm stirring at
25 °C. All proteins were reduced prior to the experiment by the addition
of excess dithionite which was removed by gel ﬁltration chromato-
graphy using either a Superdex 200 (for Aio) or 75 (for cytochrome c)
gel ﬁltration column (GE Healthcare). ITC experiments were performed
Fig. 1. Structure of Aio (AioA, green and AioB, blue) with ar-
senite (purple) and cytochrome c (pink). The molybdenum
centre is shown as a blue ball (Mo) and sticks (MGD). The [Fe-S]
clusters are shown in yellow and orange. PDB ID: 4AAY (NT-26
Aio) and 1HRC (horse-heart cytochrome c).
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on three separate occasions with three independent enzyme prepara-
tions.
2.5. Statistical analysis
The statistical signiﬁcance of the diﬀerences between WT and AioB-
F108A Aio results were determined using a Student's t-test.
2.6. X-ray crystallography of AioB-F108A mutant
The puriﬁed AioB-F108A mutant was subjected to crystallization
experiments, based on the previously reported crystallization condi-
tions used for the Aio [8]. Crystals were obtained using the sitting drop
vapor diﬀusion method, where droplets consisting of 2 μL of protein at
12.15 mg/mL and 1 μL of reservoir solution were equilibrated against
500 μL of reservoir solution containing 0.1 M Hepes sodium pH 7–8, 2%
PEG 400, 2 M ammonium sulfate. Yellowish crystals grew as thin plates
within 3–7 days. For data collection, protein crystals were ﬁrst trans-
ferred into the harvesting solution (0.1 M Hepes sodium pH 7.5, 2%
PEG 400, 2.2 M ammonium sulfate), then into cryoprotectant solution
(harvesting solution supplemented with 20% glycerol) and ﬁnally ﬂash-
frozen in liquid nitrogen. Diﬀraction experiments were carried out at
the PXIII beamline at the Swiss Light Source; the crystals diﬀracted up
to a maximum resolution of 2.2 Å (data collection statistics are pro-
vided in Table S1). Using X-rays of 1 Å wavelength, a complete data set
was collected, processed and scaled using the XDS program package
[20]. Data quality was analysed using Aimless from the CCP4 package
[21,22] and structure determination was accomplished by rigid body
reﬁnement using Refmac5 [23] with the crystal structure of WT NT-26
Aio as the search model. An anomalous electron density map was
generated using CAD and FFT [24]. Interactive cycles of model building
and reﬁnement were performed with COOT [25] and Refmac5 [23]
software (reﬁnement statistics are shown in Table S1). The atomic co-
ordinates of the AioB-F108A mutant have been deposited in the PDB
ID:5NQD.
2.7. EPR titration of AioB-F108A mutant
EPR spectroscopy was performed on WT and F108A variant en-
zymes obtained after the desalting step. Redox titrations were per-
formed at 15 °C, pH 7, as described by Dutton [26] and adapted as
described by Duval [27] in the presence of the following redox med-
iators at 100 mM: 1,4 p-benzoquinone, DCPIP, 2,5-dimethyl-p-benzo-
quinone, 2-hydroxy 1,2-naphthoquinone, 1,4-naphthoquinone. Re-
ductive titrations were carried out using sodium dithionite, and
oxidative titrations were carried out using ferricyanide. EPR spectra
were recorded on a Bruker ElexSys X-band spectrometer ﬁtted with an
Oxford Instruments liquid-Helium cryostat and temperature control
system. Evaluation were performed on the g = 1.88 signal.
Fig. 2. Results of measurements of kinetic and thermo-
dynamic parameters of WT Aio. A) Reductive half-reaction
of Aio with arsenite. Inset: change in absorbance at 450 nm
with single exponential ﬁt (red line). B) Reduction of cy-
tochrome c by Aio and arsenite. Inset: change in absorbance
at 551 nm with double exponential ﬁt (red line). Stopped-
ﬂow results are the average of 4–6 repeats with one enzyme
preparation. C) Steady-state kinetics of cytochrome c and
Aio with excess arsenite ﬁt with the Michaelis-Menten
model (red line). Results are the average of three separate
enzyme preparations. S.A. stands for speciﬁc activity. D)
Upper panel: ITC raw thermogram of Aio titrated against
cytochrome c. Lower panel: Heats integrated with respect to
time and plotted against molar ratio with a 1:1 binding ﬁt
(black line). Results are the average of three separate en-
zyme preparations.
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3. Results and discussion
3.1. The reductive half-reaction of Aio
There are four electron transfer events in the proposed electron
pathway for arsenite oxidation catalysed by Aio: arsenite to the mo-
lybdenum centre, from the molybdenum centre to the 3Fe-4S cluster,
from the 3Fe-4S cluster to the Rieske 2Fe-2S cluster and ﬁnally from the
Rieske 2Fe-2S cluster to the terminal electron acceptor [13]. Because
the molybdenum centre and the Fe-S clusters have distinct spectral
signatures at 680 nm and 450 nm, respectively [6,10], their reduction
in the course of the reaction of Aio with arsenite could be followed
independently by stopped-ﬂow UV–visible spectroscopy.
In a stopped-ﬂow experiment with Aio, reaction with arsenite re-
sults in the immediate quenching of the 680 nm absorption band within
the mixing dead-time (~1 ms) of the instrument, which implies that the
molybdenum centre was reduced by arsenite at a rate of> 4000 s−1.
The quenching of the 450 nm band occurred at an arsenite-independent
rate of 592 ± 20 s−1 and was monophasic, suggesting that electron
transfer rates from the Mo site to the proximal Fe-S and from the
proximal to the distal Fe-S are similar and indistinguishable via the
exponential ﬁtting procedure or alternatively the measured rate re-
presents the ET to the distal Fe-S while the ET from the proximal to the
distal centre is considerably faster. Considering that the rates of ET
from the Mo centre are typically limited by product release, the latter
possibility seems more likely (Fig. 2A).
The very rapid reduction of the molybdenum centre of Aio is at the
high end of rate constants observed for the reduction of molybdenum
centres for molybdoenzymes, which are quite variable. The reductive
half-reaction of DMSO reductase from Rhodobacter capsulatus, however,
also occurs within the mixing dead time at 10 °C [28]. The mo-
lybdenum-containing formate dehydrogenase from Ralstonia eutropha,
another member of the DMSOR family, is also quite rapid with a rate of
140 s−1 at 10 °C (approximately 400 s−1 at 25 °C) [29]. Chicken liver
sulphite oxidase reacts slightly slower with sulﬁte, with a rate constant
of 150–200 s−1 at 25 °C [30]. Some of the slower rates observed are
seen with members of the xanthine oxidase family (bovine milk xan-
thine oxidase reacts with xanthine at 14 s−1 at 25 °C, and Oligotropha
carboxydovorans CO dehydrogenase reacts with CO at 11.4 s−1 at 4 °C)
[31,32]. Aio is unique among molybdoenzymes in that the Mo(V) state
is unstable and unobservable in the WT enzyme [9,10], and this may be
important in rate acceleration at the active site. However, since the
reduction of the molybdenum centre occurs in the mixing dead-time for
both Aio and the R. capsulatus DMSO reductase (which has a stable Mo
(V) state [33]), it is not possible to compare their rates to conclude that
cooperative electron transfer is important in rapid reaction rates.
The reduction potentials of the molybdenum centre, [3Fe-4S] and
Rieske cofactors are similar at +240 mV, +270 mV and +225 mV,
respectively [8,10,34]. It is unlikely that diﬀerences between the co-
factor reduction potentials plays a large role in deﬁning electron
transfer rates. The rate of [Fe-S] cluster reduction is most likely limited
by dissociation of the arsenate product from the Mo active site.
The Fe-S clusters of Aio appear to become reduced simultaneously,
consistent with the apparent two-electron re-oxidation of the reduced
Mo(IV) centre and failure to observe the Mo(V) state. In most mo-
lybdoenzymes, the Mo(V) is suﬃciently stable to allow the mo-
lybdenum centre to act as a transducer between obligate one- and two-
electron transfer centres [35]. The hydrogen-bonding network of the
MGD cofactor in Aio appears to have been highly optimised to desta-
bilise the Mo(V) state [10], perhaps due to the instability of As(IV),
which rapidly decays to As(V) and superoxide [36]. This may have
provided evolutionary selection pressure to eliminate one-electron
transfer between arsenite and the molybdenum centre. This being the
case, the presence of two Fe-S clusters would be required to permit
immediate re-oxidation of the molybdenum centre, allowing the en-
zyme to act as a transducer and couple the oxidation of arsenite to the
reduction of a physiological electron acceptor that can only accept one
electron at a time.
3.2. The rate of cytochrome c reduction by Aio
The ﬁnal step in arsenite oxidation is electron transfer from the
Rieske 2Fe-2S cluster to the terminal electron acceptor [13]. NT-26 Aio
is able to reduce both the native cytochrome c552 [37] and horse heart
cytochrome c [14,37].
The reduction of cytochrome c by Aio and arsenite is found to be
biphasic (Fig. 2B). The ﬁrst phase accounts for 97% of the absorbance
change and has a rate constant of 389 ± 7 s−1. The second phase has a
rate constant of 11 ± 6 s−1 and is probably due to Aio and cyto-
chrome c achieving equilibrium (which is likely due to the similarity in
the Rieske and heme reduction potentials of +225 mV and +250 mV,
respectively [8,38]), and is likely to be catalytically irrelevant. The
reduction of cytochrome c is the slowest process observed in the
stopped-ﬂow experiments, which means that the reduction of cyto-
chrome c is the rate-limiting step in overall catalysis.
To further support the conclusion that reduction of cytochrome c is
rate-limiting, the steady-state kinetics of Aio with cytochrome c and
excess arsenite were measured using 2.5 mM arsenite and 10, 5, 4, 3, 2,
1 and 0.5 μM cytochrome c (Fig. 2C). The kcat was 427 ± 32 s−1,
which is very similar to the rate of electron transfer from the Rieske
cluster to cytochrome c observed in the stopped-ﬂow experiments and
in good agreement with previously reported values [14]. The KM for
cytochrome c was 1.0 ± 0.1 μM, and the KM for arsenite was pre-
viously reported to be 9.3 ± 1.5 μM [14].
The interaction between Aio and cytochrome c was studied further
by ITC and the Kd for cytochrome c was 2.3 ± 0.7 μM (Fig. 2D and
Table 1), which is slightly higher than the KM. The similar values for Kd
and Km for cytochrome c suggest that either electron transfer or product
release (as opposed to substrate binding) is rate-limiting, which is not
uncommon in enzymes that follow Michaelis-Menten kinetics under
saturating conditions [39]. It is unlikely that product release is rate-
limiting as this would have resulted in k551 (the rate of cytochrome c
reduction observed by stopped-ﬂow) being greater than kcat as the
former reﬂects the rate of binding and electron transfer to cytochrome c
but not product release. Conversely, the kcat/KM ratio was
4 × 108 M−1 s−1 which would suggest that the enzyme is ‘catalytically
perfect’, meaning that the reaction with cytochrome c is diﬀusion-lim-
ited (and therefore electron transfer would not be rate-limiting) [40].
While strictly speaking both these models are accurate for single sub-
strate enzymes, as the KM's of the substrates of double displacement
reactions are often altered by the rate of the other half-reaction [41],
we consider it more likely that electron transfer is most likely rate-
limiting as ‘catalytic perfection’ is a very rare phenomenon.
Rieske proteins have highly tuneable reduction potentials as well as
Table 1
Thermodynamic parameters of the binding of cytochrome c with WT Aio and AioB-F108A.
Aio kd (μM) ΔH (kcal mol−1) ΔS (cal mol−1 deg−1) Stoichiometry
WT 2.3 ± 0.7 6.0 ± 0.1 46.1 ± 1.1 0.85 ± 0.15
AioB-F108A 7.8 ± 1.7 3.0 ± 0.3 33.5 ± 1.1 0.82 ± 0.23
Results are the averages and standard deviations of three experiments with three separate enzyme preparations.
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high structural plasticity, suggesting that they may be involved in
electron transfers where the reduction potential has to be very speciﬁc
or where high promiscuity is beneﬁcial [42,43]. An example of the
Rieske protein's high tuneability has been demonstrated via point mu-
tations that alter the hydrogen bonding network of the bc1 Rieske
cluster which induced changes in the reduction potential as large as
130 mV with subsequent reductions in enzyme activity with cyto-
chrome c [44]. Members of the Rieske dioxygenase family tend to ex-
hibit a high degree of substrate promiscuity [45–47]. Gene knock out
studies have also shown that NT-26 is able to metabolise arsenite in the
absence of the native cytochrome c552 suggesting that the NT-26 Aio is
able to use alternative electron acceptors in vivo [5]. In fact, the ability
to use alternative electron acceptors has also been observed with the
arsenite oxidases from Alcaligenes faecalis [6] and Ralstonia sp. 22 [7].
There is also growing support for models of modular electron transport
chains with high degrees of plasticity, in which diﬀerent protein-pro-
tein complexes form to respond dynamically to changes in the en-
vironment [48–50]. It is therefore possible that electron transfer from
the Rieske cluster is rate-limiting in Aio as the structure has been
compromised to work with multiple electron acceptors as opposed to
optimised for one.
3.3. The eﬀect of the AioB-F108A substitution on Aio activity
The Rieske subunit of NT-26 AioB lacks a disulphide bridge prox-
imal to the 2Fe-2S cluster, instead containing a phenylalanine and a
glycine at the positions otherwise occupied by cysteines in betapro-
teobacterial arsenite oxidase [8]. Mutation of AioB Phe 108 to Ala
(F108A) was made to analyse what eﬀect, if any, removal of the large,
hydrophobic and aromatic phenylalanine had on enzyme activity. With
cytochrome c as an electron acceptor, the kcat was 14.2 ± 0.2 s−1,
approximately 30-fold lower than that observed with the WT enzyme (t-
test p = 0.0001). On the other hand, the KM's for arsenite and cyto-
chrome c were 2.0 ± 0.4 μM and 1.2 ± 0.3 μM, respectively
(Fig. 3C), essentially unchanged from the WT enzyme. This mutation
thus results in a 97% reduction in activity with no signiﬁcant change in
the KM of cytochrome c (t-test p = 0.2377).
When DCPIP was used as the electron acceptor, the AioB-F108A
mutant showed increased activity. WT Aio was previously reported to
have a Vmax of 4.8 ± 0.03 μmol min−1 mg−1, KM for arsenite of
68.0 ± 4.8 μM and kcat of 8.8 ± 0.7 s−1 (activity values were in-
correctly calculated in the original paper due to the use of the wrong
extinction coeﬃcient as explained in the methods) [8]. The AioB-F108A
mutant had a signiﬁcantly higher activity than WT Aio with a Vmax of
5.8 ± 0.2 μmol min−1 mg−1 (t-test p = 0.001). KM for arsenite of
94.6 ± 8.5 and kcat of 10.9 ± 0.4 s−1. To examine the possible con-
tribution of the shift in redox potential of the 2Fe2S cluster on the
higher activity, we performed a redox titration of the Rieske from the
F108A, followed by EPR. The results demonstrate similar redox po-
tentials at +205 ± 10 mV (compared to +225 ± 10 mV in WT). We
propose therefore that the higher activity, when DCPIP is used, is most
likely due to increased access of DCPIP to the Rieske cluster. This is
supported by the crystal structure of the F108A mutant (see below). The
improved activity with DCPIP but decreased activity with cytochrome c
made F108A an interesting mutant to study the nature of the rate-
limiting step of catalysis.
Stopped-ﬂow kinetics experiments showed that the F108A mutant
had a virtually identical reductive half-reaction to the WT Aio (Fig. 3A),
with the reduction of the molybdenum centre (680 nm) too rapid to be
observed and the simultaneous reduction of the Fe-S clusters (450 nm)
occurring at a rate of 564 ± 46 s−1, which is agreement with the
unchanged redox potential of the Rieske cluster. The reduction of cy-
tochrome c (551 nm) by Aio and arsenite, on the other hand, was tri-
phasic (Fig. 3B). The ﬁrst phase appeared to be the reduction of Aio by
arsenite which resulted in a decrease in absorbance as opposed to the
expected increase seen upon reduction of cytochrome c. It was also
similar to the value for reduction at 450 nm seen in the previous ex-
periments with a rate of 738 ± 144 s−1. The second phase accounted
for 84% of the total absorbance change, with a rate constant of
9.2 ± 0.4 s−1 and corresponding to the reduction of cytochrome c by
Aio. This rate constant is similar to the kcat for the AioB-F108A again
implying that reduction of cytochrome c is principally the rate-limiting
step. The ﬁnal phase of the reaction had a rate constant of
1.6 ± 0.4 s−1 and again appears to be due to equilibration between
Aio and cytochrome c. The principal eﬀect of the AioB-F108A sub-
stitution is reduced ET to cytochrome c.
3.4. The crystal structure of the AioB-F108A mutant
To structurally characterize AioB-F108A, the mutant was crystal-
lized and the structure determined to 2.2 Å resolution. The obtained
model shows that the overall structure is very similar to the WT Aio,
with a rmsd of 0.157 Å upon superposition of 843 residues. The reﬁned
model ﬁts the electron density map at the mutated site, as observed in
Fig. 4. When comparing the structure of WT Aio and AioB-F108A it
becomes clear that the side chain of F108 is partially covering the
Rieske, acting as a cap that protects the metal cluster from solvent in-
teractions. This eﬀect is not so pronounced for AioB-F108A since the
very small side chain of alanine is likely to allow better access of small
molecules such as DCPIP to the Fe/S center for electron transfer, which
may explain the increased Vmax of this mutant with DCPIP.
3.5. The AioB-F108A substitution eﬀect on cytochrome c binding and
aﬃnity
The AioB-F108A substitution signiﬁcantly reduced the rate of cy-
tochrome c reduction in the course of turnover. It could do this either
by lowering the aﬃnity of Aio for cytochrome c or by aﬀecting the rate
of electron transfer, and ITC was thus used to analyse the AioB-F108A/
cytochrome c aﬃnity. The Kd was found to be 7.8 ± 1.7 μM (Fig. 3D).
While the diﬀerence between the WT Aio and the AioB-F108A mutant is
signiﬁcant (t-test p = 0.0067), it is only a 3-fold increase and the data
suggest that the AioB-F108A substitution has not dramatically altered
cytochrome c aﬃnity. The mutation must therefore exert its inﬂuence
on activity through another means.
A comparison of the binding parameters of cytochrome c with WT
Aio and AioB-F108A is shown in Table 1. The F108A mutation caused
the ΔH to drop by 50% while the ΔS decreased by only 27%. The
propensity for endothermic reactions to occur increases as the ΔS be-
comes more positive and decreases as the ΔH becomes more positive.
These results suggest that the presence of F108 has a relatively neutral
function in complex formation as both the ΔH and ΔS of cytochrome c
binding to F108A are smaller compared to WT. It therefore appears that
the AioB-F108 is not critical to cytochrome c association but instead is
important for electron transfer to cytochrome c. The AioB-F108 residue
thus plays only a small role in the binding process, but once the pro-
tein:protein complex forms it is important in bringing the two proteins
into the correct orientation for electron transfer and/or in providing an
eﬀective electron transfer pathway between the Rieske 2Fe-2S cluster
and heme c of the cytochrome. The rate of electron transfer ex-
ponentially decreases as distance increases meaning a relatively minor
change in the complex structure can result in dramatic reductions in
rate [51].
The arsenite oxidases appear to show selectivity towards diﬀerent
electron acceptors which appear to coincide with their phylogeny ra-
ther than the reduction potential of the electron acceptor [5–7,27]. NT-
26, a member of the Alphaproteobacteria, can use cytochrome c
whereas members of the Betaproteobacteria like A. faecalis can use
some unrelated c-type cytochromes and azurin [5–7]. The main dif-
ference between the Rieske subunits is the absence of a disulphide
bridge in arsenite oxidases from the Alphaproteobacteria, the cysteines
replaced with a glycine and phenylalanine [27]. The presence of the
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disulphide bridge has been shown to have an signiﬁcantly smaller eﬀect
on the redox potential of the Rieske cluster in Aio (by 35 mV) [8] than
in the bc1 complex (by 54–139 mV) [52–54]. In the latter, its removal
does aﬀect the oxidation of ubiquinol by the bc1 complex. It has been
previously suggested that, in the case of Aio, the presence or absence of
the disulphide bridge modulates the electron acceptor selectivity of Aio
rather than modulating the redox potential of its Fe-S cluster [7–27].
Results of this study support this notion as the AioB-F108 appears to be
important for electron transfer to cytochrome c by bringing the heme of
cytochrome c closer to the Rieske cluster and/or providing a path for
Fig. 3. Results of measurements of kinetic and
thermodynamic parameters of the AioBF108A
mutant. A) Reductive half-reaction of F108A with
arsenite. Inset: change in absorbance at 450 nm
with single exponential ﬁt (red line). B)
Reduction of cytochrome c by F108A and ar-
senite. Inset: change in absorbance at 551 nm
with triple exponential ﬁt (red line). Stopped-
ﬂow results are the averages of 4–6 repeats with
one enzyme preparation. C) Steady-state kinetics
of cytochrome c and F108A with excess arsenite
ﬁt with the Michaelis-Menten model (red line).
Results are the average of three separate enzyme
preparations. S.A. stands for speciﬁc activity. D)
Upper panel: ITC raw thermogram of F108A ti-
trated against cytochrome c. Lower panel: Heats
integrated with respect to time and plotted
against molar ratio with a 1:1 binding ﬁt (black
line). Results are the average of three separate
enzyme preparations.
Fig. 4. Molecular details of the Rieske cluster of
NT-26 AioB. A) Crystal structures of AioB-F108A
with the electron density map contoured at 1 σ.
B) Crystal structure of the WT AioB.
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electron transfer.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbabio.2017.08.003.
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